Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca

International Journal of Antimicrobial Agents

Volumn 46, Issue 1, 2015, Pages 108-110

  Jayol, Aurélie ^a   Poirel, Laurent ^a   Villegas, Maria Virginia ^b   Nordmann, Patrice ^a,c  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^c Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

PhoPQ regulatory system; Polymyxin; Resistance

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA; MEMBRANE PROTEIN; TRANSPOSON;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; COLOMBIA; CONTROLLED STUDY; DNA FLANKING REGION; GENE AMPLIFICATION; GENE EXPRESSION; GENE INSERTION SEQUENCE; GENE SEQUENCE; GENETIC COMPLEMENTATION; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MGRB GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PHOP GENE; PHOQ GENE; PMRA GENE; PMRB GENE; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT PLASMID; START CODON; AGED; CASE REPORT; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MALE; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PLASMID; POLYMERASE CHAIN REACTION; TRANSPOSON;

AGED; ANTI-BACTERIAL AGENTS; CLONING, MOLECULAR; COLISTIN; COLOMBIA; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; GENETIC COMPLEMENTATION TEST; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; PLASMIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84935011150     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.02.015     Document Type: Article

References (15)

1. Hoenigl M, Valentin T, Zarfel G, Wuerstl B, Leitner E, Salzer HJ, et al. Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria. Antimicrob Agents Chemother 2012;56:2158-61.
2. Zarate MS, Gales AC, Picao RC, Pujol GS, Lanza A, Smayevsky J. Outbreak of OXY-2-producing Klebsiella oxytoca in a renal transplant unit. J Clin Microbiol 2008;46:2099-101.
3. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, et al. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010;35:194-9.
4. Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev 2008;21:449-65.
5. Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Clin Infect Dis 2007;45:594-8.
6. Ah YM, Kim AJ, Lee JY. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 2014;44:8-15.
7. Cannatelli A, D'Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S, et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemase mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 2013;57:5521-6.
8. Cannatelli A, Di Pilato V, Giani T, Arena F, Ambretti S, Gaibani P, et al. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob Agents Chemother 2014;58:4399-403.
9. Jayol A, Poirel L, Brink A, Villegas MV, Yilmaz M, Nordmann P. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 2014;58:4762-6.
10. Poirel L, Jayol A, Bontron S, Villegas MV, Özdamar M, Türkoglu S, et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 2015;70:75-80.
11. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014;19, pii:20939.
12. Cheng HY, Chen YF, Peng HL. Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43. J Biomed Sci 2010;17:60.
13. Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, et al. MgrB inactivation is a common mechanism of colistin resistance in KPC carbapenemase-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 2014;58:5696-703.
14. Lippa AM, Goulian M. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet 2009;5:e1000788.
15. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005;43:4178-82.